Managing Cardiovascular Risk in Patients With Chronic Kidney Disease

Rajiv Agarwal, MD


September 18, 2023

Patients with chronic kidney disease (CKD) are at significantly increased risk for serious cardiovascular (CV) events and require a personalized strategy for CV risk management to reduce cardiovascular morbidity and mortality.

In this ReCAP, Dr Rajiv Agarwal of Indiana University, Indianapolis, Indiana, highlights a proactive approach to CV risk management in patients with nondialysis CKD, including measuring albuminuria more frequently, discussing lifestyle modifications with patients, and prescribing cardioprotective therapies that have shown to be effective for reducing CKD progression and/or CV events in patients with CKD.

Dr Agarwal also discusses the ongoing FLOW trial, which will evaluate the effect of semaglutide on kidney outcomes in participants with CKD and type 2 diabetes.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.